Chimera Investment (CIM)
(Delayed Data from NYSE)
$11.80 USD
-0.09 (-0.76%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $11.79 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.80 USD
-0.09 (-0.76%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $11.79 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth B Momentum F VGM
Zacks News
Implied Volatility Surging for Chimera Investment (CIM) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Chimera Investment (CIM) stock based on the movements in the options market lately.
Chimera (CIM) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Chimera (CIM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Chimera Investment (CIM) Q1 Earnings Top Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 20% and 1.50%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Altisource Portfolio Solutions (ASPS) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Altisource Portfolio (ASPS) delivered earnings and revenue surprises of 23.08% and 11.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Matches Q4 Earnings Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 0% and 0.84%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Altisource Portfolio Solutions (ASPS) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Altisource Portfolio (ASPS) delivered earnings and revenue surprises of -29.41% and 10.99%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the Invesco KBW High Dividend Yield Financial ETF (KBWD)?
by Zacks Equity Research
Sector ETF report for KBWD
Chimera Investment (CIM) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -20% and 16.65%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Redwood Trust (RWT) Q2 Earnings Top Estimates
by Zacks Equity Research
Redwood Trust (RWT) delivered earnings and revenue surprises of 40% and 12.07%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Blackstone Mortgage Trust (BXMT) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Blackstone Mortgage (BXMT) delivered earnings and revenue surprises of 14.49% and 3.23%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Chimera Investment (CIM) Stock?
by Zacks Equity Research
Investors need to pay close attention to Chimera Investment (CIM) stock based on the movements in the options market lately.
Arbor Realty Trust (ABR) Soars 7.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Arbor Realty Trust (ABR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Chimera Investment (CIM) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -31.58% and 19.59%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
New York Mortgage Trust (NYMT) Q1 Earnings Match Estimates
by Zacks Equity Research
New York Mortgage Trust (NYMT) delivered earnings and revenue surprises of 0% and 29.08%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Apollo Commerical Finance (ARI) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Apollo Commerical Finance (ARI) delivered earnings and revenue surprises of 11.63% and 3.92%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -54.17% and 17.88%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Red River Bancshares (RRBI) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Red River Bancshares (RRBI) delivered earnings and revenue surprises of 10.94% and 0.29%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 8% and 1.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Chimera Investment (CIM) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for September 29th
by Zacks Equity Research
CIM, CUBI and ILPT have been added to the Zacks Rank #5 (Strong Sell) List on September 29, 2022.
Chimera Investment (CIM) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of -16.22% and 12.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Chimera Investment (CIM) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Chimera Investment (CIM) stock based on the movements in the options market lately.
Chimera Investment (CIM) Matches Q1 Earnings Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 0% and 2.68%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Chimera (CIM) delivered earnings and revenue surprises of 6.98% and 3.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chimera Investment (CIM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.